The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, G. H.
Right arrow Articles by Standiford, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, G. H.
Right arrow Articles by Standiford, T. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Genes and Gene Therapy
The Journal of Immunology, 2000, 165: 6496-6503.
Copyright © 2000 by The American Association of Immunologists

Intrapulmonary TNF Gene Therapy Reverses Sepsis-Induced Suppression of Lung Antibacterial Host Defense1

Gina H. Chen*, Raju C. Reddy*, Michael W. Newstead*, Kazuhiro Tateda{dagger}, Bhavani L. Kyasapura* and Theodore J. Standiford2,*

* Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, MI 48109; and {dagger} Department of Microbiology, Toho University, Tokyo, Japan

Sepsis syndrome is frequently complicated by the development of nosocomial infections, particularly Gram-negative pneumonia. Although TNF-{alpha} (TNF) has been shown to mediate many of the pathophysiologic events in sepsis, this cytokine is a critical component of innate immune response within the lung. Therefore, we hypothesized that the transient transgenic expression of TNF within the lung during the postseptic period could augment host immunity against nosocomial pathogens. To test this, mice underwent 26-gauge cecal ligation and puncture (CLP) as a model of abdominal sepsis, followed 24 h later by intratracheal (i.t.) administration of Pseudomonas aeruginosa. In animals undergoing sham surgery followed by bacterial challenge, Pseudomonas were nearly completely cleared from the lungs by 24 h. In contrast, mice undergoing CLP were unable to clear P. aeruginosa and rapidly developed bacteremia. Alveolar macrophages (AM) recovered from mice 24 h after CLP produced significantly less TNF ex vivo, as compared with AM from sham animals. Furthermore, the adenoviral mediated transgenic expression of TNF within the lung increased survival in CLP animals challenged with Pseudomonas from 25% in animals receiving control vector to 91% in animals administered recombinant murine TNF adenoviral vector. Improved survival in recombinant murine TNF adenoviral vector-treated mice was associated with enhanced lung bacterial clearance and proinflammatory cytokine expression, as well as enhanced AM phagocytic activity and cytokine expression when cultured ex vivo. These observations suggest that intrapulmonary immunostimulation with TNF can reverse sepsis-induced impairment in antibacterial host defense.




This article has been cited by other articles:


Home page
J. Immunol.Home page
F. Pene, B. Zuber, E. Courtine, C. Rousseau, F. Ouaaz, J. Toubiana, A. Tazi, J.-P. Mira, and J.-D. Chiche
Dendritic Cells Modulate Lung Response to Pseudomonas aeruginosa in a Murine Model of Sepsis-Induced Immune Dysfunction
J. Immunol., December 15, 2008; 181(12): 8513 - 8520.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. E. O. Baleeiro, P. J. Christensen, S. B. Morris, M. P. Mendez, S. E. Wilcoxen, and R. Paine III
GM-CSF and the impaired pulmonary innate immune response following hyperoxic stress
Am J Physiol Lung Cell Mol Physiol, December 1, 2006; 291(6): L1246 - L1255.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. T. Sadikot, H. Zeng, M. Joo, M. B. Everhart, T. P. Sherrill, B. Li, D.-s. Cheng, F. E. Yull, J. W. Christman, and T. S. Blackwell
Targeted Immunomodulation of the NF-{kappa}B Pathway in Airway Epithelium Impacts Host Defense against Pseudomonas aeruginosa.
J. Immunol., April 15, 2006; 176(8): 4923 - 4930.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. K. Varma, M. Durham, E. D. Murphey, W. Cui, Z. Huang, C. Y. Lin, T. Toliver-Kinsky, and E. R. Sherwood
Endotoxin Priming Improves Clearance of Pseudomonas aeruginosa in Wild-Type and Interleukin-10 Knockout Mice
Infect. Immun., November 1, 2005; 73(11): 7340 - 7347.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. Sterns, N. Pollak, B. Echtenacher, and D. N. Mannel
Divergence of Protection Induced by Bacterial Products and Sepsis-Induced Immune Suppression
Infect. Immun., August 1, 2005; 73(8): 4905 - 4912.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. T. Sadikot, T. S. Blackwell, J. W. Christman, and A. S. Prince
Pathogen-Host Interactions in Pseudomonas aeruginosa Pneumonia
Am. J. Respir. Crit. Care Med., June 1, 2005; 171(11): 1209 - 1223.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. Moriyama, A. Ishizaka, M. Nakamura, H. Kubo, T. Kotani, S. Yamamoto, E. N. Ogawa, O. Kajikawa, C. W. Frevert, Y. Kotake, et al.
Enhancement of the endotoxin recognition pathway by ventilation with a large tidal volume in rabbits
Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1114 - L1121.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. T. Sadikot, H. Zeng, F. E. Yull, B. Li, D.-s. Cheng, D. S. Kernodle, E. D. Jansen, C. H. Contag, B. H. Segal, S. M. Holland, et al.
p47phox Deficiency Impairs NF-{kappa}B Activation and Host Defense in Pseudomonas Pneumonia
J. Immunol., February 1, 2004; 172(3): 1801 - 1808.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. I. Ojielo, K. Cooke, P. Mancuso, T. J. Standiford, K. M. Olkiewicz, S. Clouthier, L. Corrion, M. N. Ballinger, G. B. Toews, R. Paine III, et al.
Defective Phagocytosis and Clearance of Pseudomonas aeruginosa in the Lung Following Bone Marrow Transplantation
J. Immunol., October 15, 2003; 171(8): 4416 - 4424.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. E. O. Baleeiro, S. E. Wilcoxen, S. B. Morris, T. J. Standiford, and R. Paine III
Sublethal Hyperoxia Impairs Pulmonary Innate Immunity
J. Immunol., July 15, 2003; 171(2): 955 - 963.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J.-M. Sallenave, G. A. Cunningham, R. M. James, G. McLachlan, and C. Haslett
Regulation of Pulmonary and Systemic Bacterial Lipopolysaccharide Responses in Transgenic Mice Expressing Human Elafin
Infect. Immun., July 1, 2003; 71(7): 3766 - 3774.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. Nakamura, Y. Mori, K. Hagiwara, T. Suzuki, T. Sakakibara, T. Kikuchi, T. Igarashi, M. Ebina, T. Abe, J. Miyazaki, et al.
Increased Susceptibility to LPS-induced Endotoxin Shock in Secretory Leukoprotease Inhibitor (SLPI)-deficient Mice
J. Exp. Med., March 3, 2003; 197(5): 669 - 674.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
S B Gordon and R C Read
Macrophage defences against respiratory tract infections: The immunology of childhood respiratory infections
Br. Med. Bull., March 1, 2002; 61(1): 45 - 61.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Wu, S. Hussain, Y.-H. He, R. Pasula, P. A. Smith, and W. J. Martin II
Genetically engineered macrophages expressing IFN-gamma restore alveolar immune function in scid mice
PNAS, November 20, 2001; (2001) 251451498.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. J. Simpson, W. A. H. Wallace, M. E. Marsden, J. R. W. Govan, D. J. Porteous, C. Haslett, and J.-M. Sallenave
Adenoviral Augmentation of Elafin Protects the Lung Against Acute Injury Mediated by Activated Neutrophils and Bacterial Infection
J. Immunol., August 1, 2001; 167(3): 1778 - 1786.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Wu, S. Hussain, Y.-H. He, R. Pasula, P. A. Smith, and W. J. Martin II
Genetically engineered macrophages expressing IFN-gamma restore alveolar immune function in scid mice
PNAS, December 4, 2001; 98(25): 14589 - 14594.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.